Delivery Order SPE2DE24DA017-SPE2D626F1497
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $3,712.50 for a Proximal Tenodesis Implant System under the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on May 29, 2025, with an ultimate completion date of June 3, 2025. The award represents work to be performed in Naples, Florida, and was issued without a set-aside...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a $26,974 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for a Proximal Tenodesis Implant System. The contract was awarded on May 27, 2025, with an ultimate completion date of May 30, 2025, and will be performed in Naples, Florida. This delivery order carries no set-aside designation, reflecting Arthrex's strong competitive position...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $26,775.30 for an Implant System, Sutureloc on September 7, 2025, with an ultimate completion date of September 19, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain and is not set aside for any specific business type. The delivery order will be performed in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,217.50 to Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida. This fixed-price contract with economic price adjustment authority is for the delivery of specialized orthopedic medical products and is scheduled for completion by September 30, 2025. The award was made without a set-aside designation, reflecting Arthrex's competitive strength in the federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $28,054.88 on September 4, 2025, for a Proximal Tenodesis Implant System. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 9, 2025. This award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-affiliated federal agency responsible for...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $1,073.17 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The delivery order, which is expected to be completed by August 26, 2025, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $17,189.24 on August 26, 2025, for a Proximal Tenodesis Implant System. This fixed-price delivery order with economic price adjustment is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed in Naples, Florida, with an ultimate completion date of August 29, 2025. The contract was awarded without a set-aside designation,...
- Arthrex Inc., a leading orthopedic medical device manufacturer based in Naples, Florida, has been awarded a delivery order valued at $1,595.88 under the Defense Logistics Agency's Medical Supply Chain program. This fixed-price delivery order with economic price adjustment, issued on August 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $16,820.24 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. Designated as contract 4569140234 with a fixed-price pricing structure that includes economic price adjustment provisions, this delivery order represents a non-competitive award with an ultimate completion date of September 3, 2025. The contract calls for the delivery of...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,837.44 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 7, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award for the delivery of orthopedic implant systems, surgical instruments, and related technologies. The delivery order falls under Arthrex's...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F1497Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,970 to Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida. The delivery order, issued on October 14, 2025, with an ultimate completion date of October 17, 2025, calls for the supply of a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment represents a non-set-aside competitive award to the established orthopedic supplier. The work will be performed in Naples, Florida, where Arthrex maintains its primary operations and manufacturing facilities. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1, 2029. That comprehensive IDC enables Veterans Affairs medical centers and Department of Defense healthcare systems nationwide to procure Arthrex's full portfolio of orthopedic products, including surgical implants, arthroscopic instruments, and specialized surgical systems. Arthrex has demonstrated substantial capability under this vehicle, having received over $550,000 in delivery orders to date, reflecting strong demand for its innovative orthopedic technologies across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/14/25 |